Real options in biotechnological firms valuation. An empirical analysis of european firms
Fuente:
Redalyc
Saved in:
| Main Author: | |
|---|---|
| Format: | Artículo científico |
| Language: | en |
| Published: |
Universidad Alberto Hurtado
2006
|
| Subjects: | |
| Online Access: | |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1876438814030823424 |
|---|---|
| author | Gracia Rubio Martín |
| author_facet | Gracia Rubio Martín |
| contents | Real options in biotechnological firms valuation. An empirical analysis of european firms Gracia Rubio Martín Prosper Lamothe Fernández Ingeniería Firms´ intangible assets are becoming more and more relevant in the different areas within the financial discipline. Its management, its quantification and its valuation nowadays constitute one of the main challenges which economy and business try to face. Through this paper we will evaluate some models based on the real options theory in order to estimate the intangible assets value of certain firms, specifically I+D biotechnological firms projects. With this aim, and after deep research on biotechnological industry, we will establish the parameters regarding one model which can be considered as a quantitative valuation method that we apply to a sample of biotechnological European companies. The results obtained through the empirical analysis are promising and they support the use of the real options theory to evaluate biotechnological firms. 2006 artículo científico 0718-2724 https://www.redalyc.org/articulo.oa?id=84710204 en http://www.redalyc.org/revista.oa?id=847 Journal of Technology Management & Innovation application/pdf Universidad Alberto Hurtado Journal of Technology Management & Innovation (Chile) Num.2 Vol.1 |
| format | Artículo científico |
| id | redalyc_84710204 |
| institution | Redalyc |
| language | en |
| publishDate | 2006 |
| publisher | Universidad Alberto Hurtado |
| spellingShingle | Real options in biotechnological firms valuation. An empirical analysis of european firms Gracia Rubio Martín Ingeniería Real options in biotechnological firms valuation. An empirical analysis of european firms Gracia Rubio Martín Prosper Lamothe Fernández Ingeniería Firms´ intangible assets are becoming more and more relevant in the different areas within the financial discipline. Its management, its quantification and its valuation nowadays constitute one of the main challenges which economy and business try to face. Through this paper we will evaluate some models based on the real options theory in order to estimate the intangible assets value of certain firms, specifically I+D biotechnological firms projects. With this aim, and after deep research on biotechnological industry, we will establish the parameters regarding one model which can be considered as a quantitative valuation method that we apply to a sample of biotechnological European companies. The results obtained through the empirical analysis are promising and they support the use of the real options theory to evaluate biotechnological firms. 2006 artículo científico 0718-2724 https://www.redalyc.org/articulo.oa?id=84710204 en http://www.redalyc.org/revista.oa?id=847 Journal of Technology Management & Innovation application/pdf Universidad Alberto Hurtado Journal of Technology Management & Innovation (Chile) Num.2 Vol.1 |
| title | Real options in biotechnological firms valuation. An empirical analysis of european firms |
| topic | Ingeniería |
| url | https://www.redalyc.org/articulo.oa?id=84710204 |